Surgery Partners reports Q2 adjusted EPS 21c, consensus 20c

Reports Q2 revenue $762.1M, consensus $735.57M. Wayne DeVeydt, Executive Chairman of the Board of Surgery Partners, noted, “We are proud to report strong growth in Adjusted EBITDA and revenue, both ahead of our expectations. We achieved these results by continuing to focus on exceptional clinical quality and value, operational execution and the strategic impact of physician recruiting and acquisitions. Our same-facility revenue growth of 10% on a year-to-date basis continues to demonstrate the durability and strength of the macro tailwinds associated with our long-term growth algorithm.”